Table 1.
Characteristics of included studies
| Author(year) | Country | Sample size | Mean age (range) | Study type | The position of implant | Type of implant and surface | Bone condition | Performed analysis | Evaluation time |
|---|---|---|---|---|---|---|---|---|---|
| Abohabib(2018) | Egypt | 15 | 20.9 ± 3.4 | Split mouth | Between the maxillary second premolar and first molar buccally | AbsoAnchor orthodontic mini-implants (AbsoAnchor, Dentos, Daegu, Korea) with a diameter of 1.5 mm and a length of 8 mm | NR | RFA in Hertz | Immediately and 1, 2, 3, 4, 6, 8, 10 weeks later |
| Mandić(2015) | Serbia | 12 | 61.28(55–75) | Split mouth | Premolar and/or molar maxillary regions | Self-tapping BlueSky® implants(Bredent, Germany) with a diameter of 4 mm and a length of 10 mm | Type D3 and D4 | RFA in ISQ | Immediately and 1, 2, 3, 4, 5, 6 weeks later |
| Karaca(2018) | Turkey | 25 | 51.2 ± 2.3(36–64) | NR | Posterior mandible | DTI Implant Systems(Istanbul, Turkey) with a diameter of 4 or 4.5 mm and a length of 10 mm | Minimum 12 mm above the mandibular canal and minimum 5.0 mm in width | RFA in ISQ | Immediately and 6 months later |
| García-Morales (2012) | Brazil | 8 | 36(20–55) | Split mouth | Posterior mandible | XiVE-S implants(Dentsply Friadent, Mannheim, Germany) with a diameter of 3.8 mm and a length of 11 mm | Type 2 | RFA in ISQ | Immediately,10 days and 3,6,9,12 weeks later |
| Memarian(2018) | Iran | 12 | NR | Split mouth | Mandible(one in the midline and the other two at the left and right canine teeth positions) | DIO implants (Korea) with resorbable blast media surface(invasive fungal infections-tissue level) | Type 2 or 3 | PTV | Immediately and 3,4,8 weeks later |
| Ekizer(2016) | Turkey | 20 | 16.77 ± 1.41 (13.1–19) | Split mouth | Between the roots of maxillary first molars and second premolars | Screw-shaped titanium orthodontic miniscrews with a diameter of 1.6 mm and a length of 8 mm | NR | RFA in ISQ | Immediately and 1,2,3 months later |
| Gokmenoglu (2014) | Turkey | 15 | LED:50.43 ± 9.25; C:45.87 ± 13.46 | NR | NR | XiVE implants(Dentsply-Friadent, Mannheim, Germany) with a diameter of 3.8 (3.5–4.5)mm and a length of 11.0(11–11)mm in LED group, while with a diameter of 4.5((3.8–4.5)mm and a length of 11.0 (10.6–11.0)mm in control group | Type 2 or 3 | RFA in ISQ | Immediately and 2,4,8,12 weeks later |
| Torkzaban(2017) | Iran | 19 | Female:43 Male:40.8 |
NR | Maxillary teeth | Dio implants (Dio UF, Busan, Korea) with a diameter of 4 or 4.5 mm a length of 10 or 11.5 mm | Type D3 and D4 | RFA in ISQ | Immediately,10 days and 3,6,12 weeks later |
NR Not reported, RFA Resonant frequency analysis, PTV Periotest value, ISQ Implant stability quotient, C Control group